AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24659622 — intervention group
Group type: EXPERIMENTAL
Intervention: Daptomycin
Number of subjects: 8
Study 21470787 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose external-beam radiation therapy (EBRT) (79.2 Gray equivalent using photons and protons)
Number of subjects: 282
Study 21470787 — intervention group
Group type: COMPARATOR
Intervention: Permanent prostate brachytherapy
Number of subjects: 282
Study 19865063 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam 1.5 mg daily
Number of subjects: 36
Study 19865063 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 17495708 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief personalized motivational intervention (PMI)
Number of subjects: 497
Study 17495708 — intervention group
Group type: COMPARATOR
Intervention: Brief information and advice (BIA)
Number of subjects: 497
Study 15517143 — intervention group
Group type: EXPERIMENTAL
Intervention: C-TRUS
Number of subjects: 132
Study 11548897 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg Ginkgo biloba extract EGb 761 twice daily
Number of subjects: 106
Study 11548897 — intervention group
Group type: COMPARATOR
Intervention: 12 mg Ginkgo biloba extract EGb 761 twice daily
Number of subjects: 106
Study 10385853 — intervention group
Group type: EXPERIMENTAL
Intervention: Train-of-four (TOF; 4 stimuli at 2 Hz, repeated every 12 s)
Number of subjects: 20
Study 10385853 — intervention group
Group type: COMPARATOR
Intervention: Single twitch (ST; 0.1 Hz)
Number of subjects: 20
Study 7936250 — intervention group
Group type: EXPERIMENTAL
Intervention: 1H‐MRSI in ALS patients
Number of subjects: 12
Study 7936250 — intervention group
Group type: EXPERIMENTAL
Intervention: 1H‐MRSI in ALS-PUMNS patients
Number of subjects: 12
Study 7936250 — intervention group
Group type: EXPERIMENTAL
Intervention: 1H‐MRSI in PSMA patients
Number of subjects: 12
Study 7936250 — intervention group
Group type: EXPERIMENTAL
Intervention: 1H‐MRSI in sequential studies
Number of subjects: 12
Study 7936250 — intervention group
Group type: EXPERIMENTAL
Intervention: 1H‐MRSI
Number of subjects: 12
Study 3124453 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymopentin treatment (50 mg s.c. 3 times/week for 3 weeks and repeated after 3 months at 50 mg s.c. once a week for 3 months)
Number of subjects: 0
Study 28554739 — intervention group
Group type: EXPERIMENTAL
Intervention: Descriptive norms questions (e.g., 'What do you do with bikes?')
Number of subjects: 160
Study 28554739 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference questions (e.g., 'What do you like to do with bikes?')
Number of subjects: 160
Study 28554739 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescriptive norms questions (e.g., 'What should you do with books?')
Number of subjects: 160
Study 28554739 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference questions (e.g., 'What do you like about books?')
Number of subjects: 160
Study 27889725 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mL/kg IV normal saline over 6-8 hours
Number of subjects: 55
Study 27889725 — intervention group
Group type: COMPARATOR
Intervention: Routine fluids
Number of subjects: 55
Study 25329799 — intervention group
Group type: EXPERIMENTAL
Intervention: Left temporo-parietal junction area stimulation
Number of subjects: 51
Study 25329799 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral temporo-parietal junction area stimulation
Number of subjects: 51
Study 25329799 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 51
Study 23510951 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger (1g capsules, two doses: one before induction and one 2h after surgery)
Number of subjects: 239
Study 23510951 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study 20701216 — intervention group
Group type: EXPERIMENTAL
Intervention: VivaSens
Number of subjects: 30
Study 20701216 — intervention group
Group type: EXPERIMENTAL
Intervention: Seal&Protect
Number of subjects: 30
Study 17070090 — intervention group
Group type: EXPERIMENTAL
Intervention: Mulligan's mobilization with movement (MWM) technique
Number of subjects: 24
Study 17070090 — intervention group
Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 24
Study 17070090 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 24
Study 16881064 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 18
Study 16881064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 12365892 — intervention group
Group type: COMPARATOR
Intervention: Classic parotidectomy with sacrifice of the great auricular nerve (Group A)
Number of subjects: 30
Study 12365892 — intervention group
Group type: EXPERIMENTAL
Intervention: Great auricular nerve preservation during parotidectomy (Group B)
Number of subjects: 30
Study 10200837 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep pressure using Grandin's Hug Machine
Number of subjects: 12
Study 10200837 — intervention group
Group type: COMPARATOR
Intervention: Placebo (disengaged Hug Machine)
Number of subjects: 12
Study 7767852 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1.5g once daily
Number of subjects: 31
Study 7767852 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime 6g divided into four daily doses
Number of subjects: 31
Study 2150591 — intervention group
Group type: EXPERIMENTAL
Intervention: CGS 16949A 0.9 mg
Number of subjects: 46
Study 2150591 — intervention group
Group type: EXPERIMENTAL
Intervention: CGS 16949A 0.6 mg
Number of subjects: 46
Study 314759 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine 2.5 microgram/kg . min
Number of subjects: 23
Study 314759 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine 5 microgram/kg . min
Number of subjects: 23
Study 314759 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine 10 microgram/kg . min during cardiopulmonary bypass
Number of subjects: 23
Study 31653219 — intervention group
Group type: EXPERIMENTAL
Intervention: Single follow-up home visit intervention group
Number of subjects: 544
Study 31653219 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 544
Study 28255987 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 185
Study 28255987 — intervention group
Group type: EXPERIMENTAL
Intervention: Metaraminol
Number of subjects: 185
Study 28255987 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 185
Study 25574686 — intervention group
Group type: EXPERIMENTAL
Intervention: GS-5806 (oral RSV fusion inhibitor)
Number of subjects: 0
Study 25574686 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24066179 — intervention group
Group type: EXPERIMENTAL
Intervention: Timbre manipulation (sinusoidal, flute, piano, synthetic voice tone)
Number of subjects: 0
Study 24066179 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure-tone intervals
Number of subjects: 0
Study 24066179 — intervention group
Group type: EXPERIMENTAL
Intervention: Piano tone intervals
Number of subjects: 0
Study 21839564 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-social transitional care management program (HSTCMP)
Number of subjects: 1700
Study 21839564 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1700
Study 20006808 — intervention group
Group type: EXPERIMENTAL
Intervention: Bypass surgery (BSX)
Number of subjects: 0
Study 20006808 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty (BAP)
Number of subjects: 0
Study 20006808 — intervention group
Group type: EXPERIMENTAL
Intervention: Vein BSX
Number of subjects: 0
Study 20006808 — intervention group
Group type: COMPARATOR
Intervention: Prosthetic BSX
Number of subjects: 0
Study 20006808 — intervention group
Group type: COMPARATOR
Intervention: BAP followed by BSX
Number of subjects: 0
Study 17156968 — intervention group
Group type: EXPERIMENTAL
Intervention: Personally tailored interactive multimedia computer program (IMCP)
Number of subjects: 49
Study 17156968 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-tailored IMCP 'electronic leaflet')
Number of subjects: 49
Study 15472665 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-visit root canal treatment using AH 26 sealer and laterally compacted gutta-percha
Number of subjects: 218
Study 15472665 — intervention group
Group type: COMPARATOR
Intervention: 2-visit root canal treatment with calcium hydroxide-chlorhexidine medication and temporary filling
Number of subjects: 218
Study 11340880 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive method with sensor fixed to acromion
Number of subjects: 0
Study 11340880 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive method with sensor mounted on adjustable jig
Number of subjects: 0
Study 11340880 — intervention group
Group type: COMPARATOR
Intervention: Invasive approach with pins drilled into scapula
Number of subjects: 0
Study 8980871 — intervention group
Group type: EXPERIMENTAL
Intervention: light or medication
Number of subjects: 45
Study 8435923 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 125
Study 8435923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 8435923 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (in patients with ST-segment depression)
Number of subjects: 125
Study 8435923 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in patients with ST-segment depression)
Number of subjects: 125
Study 3092658 — intervention group
Group type: EXPERIMENTAL
Intervention: Enprostil (35 micrograms twice daily)
Number of subjects: 87
Study 3092658 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 31570085 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy with the Trevo device
Number of subjects: 206
Study 31570085 — intervention group
Group type: COMPARATOR
Intervention: Best medical therapy
Number of subjects: 206
Study 29101314 — intervention group
Group type: EXPERIMENTAL
Intervention: Bryan cervical artificial disc replacement (ADR)
Number of subjects: 49
Study 29101314 — intervention group
Group type: COMPARATOR
Intervention: ACDF (anterior cervical discectomy and fusion)
Number of subjects: 49
Study 25976743 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 84
Study 25976743 — intervention group
Group type: COMPARATOR
Intervention: Zoledronic acid
Number of subjects: 84
Study 23902798 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-enhanced group tele-consultation
Number of subjects: 0
Study 23902798 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard group tele-consultation
Number of subjects: 0
Study 23902798 — intervention group
Group type: COMPARATOR
Intervention: Fidelity assessment with no consultation
Number of subjects: 0
Study 21980775 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA Supreme
Number of subjects: 60
Study 21980775 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 60
Study 19291121 — intervention group
Group type: EXPERIMENTAL
Intervention: Solvent-free (SF) formulation
Number of subjects: 12
Study 19291121 — intervention group
Group type: COMPARATOR
Intervention: Solvent-containing (SC) formulation
Number of subjects: 12
Study 16790651 — intervention group
Group type: EXPERIMENTAL
Intervention: HIGH-group: 9.5 mg hyperbaric bupivacaine + 2.5 microg sufentanil
Number of subjects: 50
Study 16790651 — intervention group
Group type: COMPARATOR
Intervention: LOW-group: 6.5 mg hyperbaric bupivacaine + 2.5 microg sufentanil
Number of subjects: 50
Study 15055096 — intervention group
Group type: EXPERIMENTAL
Intervention: Iyengar yoga course (2 classes per week for 5 weeks)
Number of subjects: 28
Study 15055096 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 28
Study 11105535 — intervention group
Group type: COMPARATOR
Intervention: Conventional amphotericin B 1 mg kg‐1 per day
Number of subjects: 193
Study 11105535 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B 1 mg kg‐1 per day
Number of subjects: 193
Study 11105535 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B 3 mg kg‐1 per day
Number of subjects: 193
Study 11105535 — intervention group
Group type: COMPARATOR
Intervention: Conventional amphotericin B
Number of subjects: 193
Study 11105535 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B 1 mg kg‐1
Number of subjects: 193
Study 11105535 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B 3 mg kg‐1
Number of subjects: 193
Study 19361151 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OCs)
Number of subjects: 10
Study 19361151 — intervention group
Group type: COMPARATOR
Intervention: Control (off OCs)
Number of subjects: 10
Study 1376826 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy
Number of subjects: 0
Study 3885425 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole tablets (2 g single dose)
Number of subjects: 3
Study 3885425 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl metronidazole suspension (2 g single dose)
Number of subjects: 3
Study 3885425 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole tablets (2 g single dose)
Number of subjects: 3
Study 3611299 — intervention group
Group type: COMPARATOR
Intervention: Oral influenza immunization in elderly volunteers
Number of subjects: 0
Study 3611299 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral influenza immunization in young mice
Number of subjects: 0
Study 3611299 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral influenza immunization in older mice
Number of subjects: 0
Study 3611299 — intervention group
Group type: COMPARATOR
Intervention: Oral influenza immunization
Number of subjects: 0
Study 3611299 — intervention group
Group type: COMPARATOR
Intervention: Parenteral influenza immunization
Number of subjects: 0
Study 3611299 — intervention group
Group type: EXPERIMENTAL
Intervention: Secretory IgA (SIgA) antibody response
Number of subjects: 0
Study 3611299 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary antibody response in elderly
Number of subjects: 0
Study 31888725 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs with poor recruitment
Number of subjects: 77
Study 31888725 — intervention group
Group type: COMPARATOR
Intervention: Completed RCTs
Number of subjects: 77
Study 28876220 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical wound dressing group
Number of subjects: 84
Study 28876220 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified surgical wound dressing group
Number of subjects: 84
Study 28876220 — intervention group
Group type: COMPARATOR
Intervention: Traditional care group
Number of subjects: 84
Study 26383578 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic knife
Number of subjects: 40
Study 26383578 — intervention group
Group type: COMPARATOR
Intervention: Electric knife
Number of subjects: 40
Study 22799766 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary educational program focusing on decreasing sodium and increasing potassium through cooking instructions and self-monitoring of the diet.
Number of subjects: 71
Study 22799766 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 71
Study 21701062 — intervention group
Group type: EXPERIMENTAL
Intervention: real repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 32
Study 21701062 — intervention group
Group type: COMPARATOR
Intervention: sham rTMS
Number of subjects: 32
Study 18444059 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based psychosocial treatments (EBTs)
Number of subjects: 0
Study 16434737 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish once/year
Number of subjects: 376
Study 16434737 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish twice/year
Number of subjects: 376
Study 16434737 — intervention group
Group type: COMPARATOR
Intervention: Counseling only
Number of subjects: 376
Study 12898088 — intervention group
Group type: COMPARATOR
Intervention: Full-vision trials (VC5)
Number of subjects: 0
Study 12898088 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocked vision trials (various latencies)
Number of subjects: 0
Study 10882226 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid (fluticasone propionate, FP, 250 microg twice daily)
Number of subjects: 30
Study 10882226 — intervention group
Group type: COMPARATOR
Intervention: Short-acting beta-agonist (salbutamol, Sb, 400 microg twice daily)
Number of subjects: 30
Study 9085466 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed casein-based formula
Number of subjects: 26
Study 9085466 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy-protein based formula
Number of subjects: 26
Study 9085466 — intervention group
Group type: COMPARATOR
Intervention: Age-matched controls on a free diet
Number of subjects: 26
Study 9085466 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CMPA groups
Number of subjects: 26
Study 8267238 — intervention group
Group type: EXPERIMENTAL
Intervention: Needleless system
Number of subjects: 97
Study 8267238 — intervention group
Group type: COMPARATOR
Intervention: Conventional heparin lock
Number of subjects: 97
Study 3884131 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) + semustine (MeCCNU) chemotherapy
Number of subjects: 180
Study 3884131 — intervention group
Group type: COMPARATOR
Intervention: Observation only (Control)
Number of subjects: 180
Study 31260569 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifrontal ECT
Number of subjects: 120
Study 31260569 — intervention group
Group type: EXPERIMENTAL
Intervention: Right unilateral ECT
Number of subjects: 120
Study 31260569 — intervention group
Group type: COMPARATOR
Intervention: Bitemporal ECT
Number of subjects: 120
Study 28759735 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mL of 2% fat milk
Number of subjects: 30
Study 28759735 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mL of soy beverage
Number of subjects: 30
Study 28759735 — intervention group
Group type: EXPERIMENTAL
Intervention: 175 g of 2% Greek yogurt
Number of subjects: 30
Study 28759735 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g of Cheddar cheese
Number of subjects: 30
Study 28759735 — intervention group
Group type: COMPARATOR
Intervention: Water (energy-free control)
Number of subjects: 30
Study 26308174 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol at siponimod steady state (group A)
Number of subjects: 76
Study 26308174 — intervention group
Group type: EXPERIMENTAL
Intervention: Siponimod at propranolol steady state (group B)
Number of subjects: 76
Study 26308174 — intervention group
Group type: COMPARATOR
Intervention: Propranolol alone (group D)
Number of subjects: 76
Study 26308174 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group C)
Number of subjects: 76
Study 26308174 — intervention group
Group type: EXPERIMENTAL
Intervention: Coadministration of siponimod and propranolol
Number of subjects: 76
Study 24050855 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon aminocaproic acid (EACA)
Number of subjects: 64
Study 24050855 — intervention group
Group type: COMPARATOR
Intervention: Tranexamic acid (TXA)
Number of subjects: 64
Study 24050855 — intervention group
Group type: EXPERIMENTAL
Intervention: Both EACA and TXA
Number of subjects: 64
Study 22068581 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced website (intervention)
Number of subjects: 24
Study 22068581 — intervention group
Group type: COMPARATOR
Intervention: Basic text-based website (comparison)
Number of subjects: 24
Study 19142758 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan (20 mg/day) administered at bedtime
Number of subjects: 123
Study 19142758 — intervention group
Group type: COMPARATOR
Intervention: Olmesartan (20 mg/day) administered upon awakening
Number of subjects: 123
Study 17209146 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment in MDD-HF subjects
Number of subjects: 61
Study 17209146 — intervention group
Group type: COMPARATOR
Intervention: Nondepressed HF subjects
Number of subjects: 61
Study 17209146 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 61
Study 15025735 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone proprionate (FP) 2000 micro g daily for 2 weeks
Number of subjects: 20
Study 11862344 — intervention group
Group type: EXPERIMENTAL
Intervention: buprenorphine/naloxone (4/1, 8/2, 16/4, 32/8 mg)
Number of subjects: 6
Study 11862344 — intervention group
Group type: EXPERIMENTAL
Intervention: buprenorphine (32 mg)
Number of subjects: 6
Study 11862344 — intervention group
Group type: EXPERIMENTAL
Intervention: buprenorphine/naloxone
Number of subjects: 6
Study 11862344 — intervention group
Group type: EXPERIMENTAL
Intervention: buprenorphine/naloxone and buprenorphine
Number of subjects: 6
Study 9814400 — intervention group
Group type: COMPARATOR
Intervention: Oral amoxicillin (50 mg/kg/day divided tid)
Number of subjects: 170
Study 9814400 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular penicillin (50,000 units/kg)
Number of subjects: 170
Study 9814400 — intervention group
Group type: EXPERIMENTAL
Intervention: General appearance in children less than two years of age
Number of subjects: 170
Study 9814400 — intervention group
Group type: COMPARATOR
Intervention: Failure by all three main outcome measures
Number of subjects: 170
Study 9814400 — intervention group
Group type: COMPARATOR
Intervention: Hospitalization at follow-up visit
Number of subjects: 170
Study 7616304 — intervention group
Group type: EXPERIMENTAL
Intervention: albendazole
Number of subjects: 407
Study 7616304 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 407
Study 2796618 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mL of 0.5% Bupivacaine
Number of subjects: 80
Study 2796618 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mL of 0.5% Bupivacaine with 1 mL 10% G/W
Number of subjects: 80
Study 2796618 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mL of 0.5% Bupivacaine with 1 mL 10% G/W
Number of subjects: 80
Study 2796618 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mL of 0.5% Bupivacaine in 8% glucose
Number of subjects: 80
Study 2796618 — intervention group
Group type: COMPARATOR
Intervention: Plain Bupivacaine
Number of subjects: 80
Study 2796618 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric Bupivacaine
Number of subjects: 80
Study 2796618 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mL of hyperbaric Bupivacaine
Number of subjects: 80
Study 648737 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium chloride (Slow‐K 600 mg three times daily)
Number of subjects: 0